92 related articles for article (PubMed ID: 9576622)
1. Effect of amino acid substitutions in the heavy chain CDR3 of an autoantibody on its reactivity.
Adib-Conquy M; Gilbert M; Avrameas S
Int Immunol; 1998 Mar; 10(3):341-6. PubMed ID: 9576622
[TBL] [Abstract][Full Text] [Related]
2. Reactivity and structure of a mouse anti-F(ab')2 IgM. Comparison of its variable region sequences with those of a structurally close polyreactive natural IgM.
Adib-Conquy M; Gilbert M; Christodoulou C; Avrameas S
Mol Immunol; 1994 May; 31(7):555-62. PubMed ID: 8190131
[TBL] [Abstract][Full Text] [Related]
3. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice.
Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A
Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911
[TBL] [Abstract][Full Text] [Related]
4. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.
Ditzel HJ; Itoh K; Burton DR
J Immunol; 1996 Jul; 157(2):739-49. PubMed ID: 8752924
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
Ichiyoshi Y; Casali P
J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
[TBL] [Abstract][Full Text] [Related]
6. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.
Martin T; Crouzier R; Weber JC; Kipps TJ; Pasquali JL
J Immunol; 1994 Jun; 152(12):5988-96. PubMed ID: 8207223
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection.
Ikematsu H; Kasaian MT; Schettino EW; Casali P
J Immunol; 1993 Oct; 151(7):3604-16. PubMed ID: 8376796
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides.
Deng YJ; Notkins AL
Clin Exp Immunol; 2000 Jan; 119(1):69-76. PubMed ID: 10606966
[TBL] [Abstract][Full Text] [Related]
9. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
[TBL] [Abstract][Full Text] [Related]
10. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamics of Fab-ssDNA interactions: contribution of heavy chain complementarity determining region 3.
Komissarov AA; Deutscher SL
Biochemistry; 1999 Nov; 38(44):14631-7. PubMed ID: 10545187
[TBL] [Abstract][Full Text] [Related]
12. Diverse binding site structures revealed in homology models of polyreactive immunoglobulins.
Ramsland PA; Guddat LW; Edmundson AB; Raison RL
J Comput Aided Mol Des; 1997 Sep; 11(5):453-61. PubMed ID: 9385549
[TBL] [Abstract][Full Text] [Related]
13. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.
Cheung SC; Takeda S; Notkins AL
Clin Exp Immunol; 1995 Aug; 101(2):383-6. PubMed ID: 7648724
[TBL] [Abstract][Full Text] [Related]
14. Human Ig heavy chain CDR3 regions in adult bone marrow pre-B cells display an adult phenotype of diversity: evidence for structural selection of DH amino acid sequences.
Raaphorst FM; Raman CS; Tami J; Fischbach M; Sanz I
Int Immunol; 1997 Oct; 9(10):1503-15. PubMed ID: 9352355
[TBL] [Abstract][Full Text] [Related]
15. Human autoantibody recognition of DNA.
Barbas SM; Ditzel HJ; Salonen EM; Yang WP; Silverman GJ; Burton DR
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2529-33. PubMed ID: 7708679
[TBL] [Abstract][Full Text] [Related]
16. Structural and affinity studies of IgM polyreactive natural autoantibodies.
Diaw L; Magnac C; Pritsch O; Buckle M; Alzari PM; Dighiero G
J Immunol; 1997 Jan; 158(2):968-76. PubMed ID: 8993018
[TBL] [Abstract][Full Text] [Related]
17. Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.
D'Angelo S; Ferrara F; Naranjo L; Erasmus MF; Hraber P; Bradbury ARM
Front Immunol; 2018; 9():395. PubMed ID: 29568296
[TBL] [Abstract][Full Text] [Related]
18. Probing the combining site of an anti-carbohydrate antibody by saturation-mutagenesis: role of the heavy-chain CDR3 residues.
Brummell DA; Sharma VP; Anand NN; Bilous D; Dubuc G; Michniewicz J; MacKenzie CR; Sadowska J; Sigurskjold BW; Sinnott B
Biochemistry; 1993 Feb; 32(4):1180-7. PubMed ID: 8424945
[TBL] [Abstract][Full Text] [Related]
19. Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells.
Im SR; Im SW; Chung HY; Pravinsagar P; Jang YJ
Mol Immunol; 2015 Oct; 67(2 Pt B):377-87. PubMed ID: 26189065
[TBL] [Abstract][Full Text] [Related]
20. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
